4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-23-125483
President and CEO acquired 40,596 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CARUSO JAMES V President and CEO | 2023-12-08 | Grant or award | +40,596 | 49,236 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CARUSO JAMES V President and CEO | 2023-06-23 | Grant or award · Stock option (right to buy) | +261,000 | 261,000 | D: show line 2 in the form |
Loading xslF345X05/tm2332764-1_4seq1.xml…